# ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

> **NCT04634357** · PHASE1,PHASE2 · RECRUITING · sponsor: **Eureka Therapeutics Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Hepatoblastoma
- Hepatocellular Carcinoma (HCC)
- Liver Neoplasms
- Metastatic Liver Cancer
- Liver Cancer
- HEMNOS

## Interventions

- **DRUG:** ET140203 T Cells

## Key facts

- **NCT ID:** NCT04634357
- **Lead sponsor:** Eureka Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-19
- **Primary completion:** 2026-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04634357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04634357, "ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04634357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*